VeroScience LLC – Trademark Portfolio
Entity Type: 16
VeroScience LLC owns a portfolio of 18 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as CYCLOSET, VEROWEAR, VEROSCIENCE, V IIX VII V VI VII VIII, and VEROWEAR IIX VII VII VI V VII. Of these, 9 are registered. The portfolio spans 4 Nice Classification classes, led by Class 5 (Pharmaceuticals) and Class 25 (Clothing). Headquartered in Tiverton, RI.
1334 Main Road
Tiverton, RI 02878
Showing of trademarks Trademarks
Trademark Classifications
VeroScience LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does VeroScience LLC have?
VeroScience LLC has 18 U.S. trademarks filed with the USPTO. Of these, 9 registered, 8 abandoned, 1 cancelled.
What trademark classes does VeroScience LLC file in?
VeroScience LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 25 (Clothing), Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are VeroScience LLC's most well-known trademarks?
VeroScience LLC's registered trademark portfolio includes well-known marks such as CYCLOSET, VEROWEAR, VEROSCIENCE, V IIX VII V VI VII VIII, and VEROWEAR IIX VII VII VI V VII. These are among 9 currently registered trademarks in the portfolio.
What is VeroScience LLC's trademark registration success rate?
VeroScience LLC has a 50% trademark registration rate, with 9 out of 18 resolved applications resulting in successful registration. Currently, 0 applications are pending review.